Search Results - "Darras, Basil"
-
1
Poly(lactic acid) (PLA) and polyhydroxyalkanoates (PHAs), green alternatives to petroleum-based plastics: a review
Published in RSC advances (10-05-2021)“…In spite of the fact that petroleum-based plastics are convenient in terms of fulfilling the performance requirements of many applications, they contribute…”
Get full text
Journal Article -
2
Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron Disease
Published in Pediatric neurology (01-08-2020)“…Spinal muscular atrophy is typically characterized as a motor neuron disease. Untreated patients with the most severe form, spinal muscular atrophy type 1, die…”
Get full text
Journal Article -
3
Spinal Muscular Atrophies
Published in The Pediatric clinics of North America (01-06-2015)“…Spinal muscular atrophies (SMAs) are hereditary degenerative disorders of lower motor neurons associated with progressive muscle weakness and atrophy. Proximal…”
Get full text
Journal Article -
4
Challenges and opportunities in spinal muscular atrophy therapeutics
Published in Lancet neurology (01-02-2024)“…Spinal muscular atrophy was the most common inherited cause of infant death until 2016, when three therapies became available: the antisense oligonucleotide…”
Get full text
Journal Article -
5
Risdiplam in Type 1 Spinal Muscular Atrophy
Published in The New England journal of medicine (11-03-2021)“…The small molecule risdiplam increased the expression of SMN protein in blood in 21 infants with type 1 spinal muscular atrophy. Post hoc clinical features of…”
Get full text
Journal Article Web Resource -
6
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls
Published in The New England journal of medicine (29-07-2021)“…The pre-mRNA SMN2 splicing modifier risdiplam was administered orally to 41 infants with type 1 spinal muscular atrophy. After 12 months of treatment, 12…”
Get full text
Journal Article Web Resource -
7
Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
Published in Neurology (08-03-2016)“…OBJECTIVE:To examine safety, tolerability, pharmacokinetics, and preliminary clinical efficacy of intrathecal nusinersen (previously ISIS-SMNRx), an antisense…”
Get full text
Journal Article -
8
Systemic nature of spinal muscular atrophy revealed by studying insurance claims
Published in PloS one (14-03-2019)“…We investigated the presence of non-neuromuscular phenotypes in patients affected by Spinal Muscular Atrophy (SMA), a disorder caused by a mutation in the…”
Get full text
Journal Article -
9
Spinal muscular atrophy
Published in Nature reviews. Disease primers (04-08-2022)“…Spinal muscular atrophy (SMA) is a neurodegenerative disorder caused by mutations in SMN1 (encoding survival motor neuron protein (SMN)). Reduced expression of…”
Get full text
Journal Article -
10
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
Published in Lancet neurology (01-04-2021)“…Spinal muscular atrophy type 1 is a motor neuron disorder resulting in death or the need for permanent ventilation by age 2 years. We aimed to evaluate the…”
Get full text
Journal Article -
11
Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studies
Published in Neurology (21-05-2019)“…OBJECTIVETo report results of intrathecal nusinersen in children with later-onset spinal muscular atrophy (SMA). METHODSAnalyses included children from a phase…”
Get full text
Journal Article -
12
Yeo and Darras: Extraneuronal Phenotypes of Spinal Muscular Atrophy
Published in Annals of neurology (01-01-2021)Get full text
Journal Article -
13
Observational study of spinal muscular atrophy type I and implications for clinical trials
Published in Neurology (26-08-2014)“…OBJECTIVES:Prospective cohort study to characterize the clinical features and course of spinal muscular atrophy type I (SMA-I). METHODS:Patients were enrolled…”
Get full text
Journal Article -
14
Revised upper limb module for spinal muscular atrophy: Development of a new module
Published in Muscle & nerve (01-06-2017)“…ABSTRACT Introduction There is a growing need for a robust clinical measure to assess upper limb motor function in spinal muscular atrophy (SMA), as the…”
Get full text
Journal Article -
15
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool
Published in PloS one (21-02-2017)“…Recent translational research developments in Spinal Muscular Atrophy (SMA), outcome measure design and demands from regulatory authorities require that…”
Get full text
Journal Article -
16
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials
Published in CNS drugs (01-09-2019)“…Background Treatment with nusinersen has demonstrated significant and clinically meaningful benefits in clinical trials in infants and children with spinal…”
Get full text
Journal Article -
17
Dystrophinopathies
Published in Seminars in neurology (01-08-2015)“…The dystrophinopathies fall along a spectrum of muscular dystrophy phenotypes, with variable involvement of skeletal and cardiac muscle. The diagnosis of…”
Get more information
Journal Article -
18
Cyber-Physical Systems as an Enabler of Circular Economy to Achieve Sustainable Development Goals: A Comprehensive Review
Published in International journal of precision engineering and manufacturing-green technology (01-05-2022)“…Industrialization has brought wealth, prosperity, and abundance to many nations. However, it has had many drawbacks on people’s health and the environment…”
Get full text
Journal Article -
19
Precious SMA natural history data: A benchmark to measure future treatment successes
Published in Neurology (21-08-2018)Get full text
Journal Article -
20
Non-5q spinal muscular atrophies: the alphanumeric soup thickens
Published in Neurology (26-07-2011)Get full text
Journal Article